GGrantIndex
← Search

PHASED GENOMICS FOR IMPROVED NONINVASIVE DIAGNOSIS AND RISK STRATIFICATION OF KIDNEY CANCERS BASED ON GENOMIC INSTABILITY AND ASSOCIATED CPG HYPERMETHYLATION.

$976,891FY2021Defense Health AgencyDOD

Regents Of The University Of Michigan

Investigators

View source on USAspending →
PHASED GENOMICS FOR IMPROVED NONINVASIVE DIAGNOSIS AND RISK STRATIFICATION OF KIDNEY CANCERS BASED ON GENOMIC INSTABILITY AND ASSOCIATED CPG HYPERMETHYLATION. · GrantIndex